Mogrify named ‘The One to Watch’ at Cambridge Independent Science and Technology Awards 2019
Mogrify named ‘The One to Watch’ at Cambridge Independent Science and Technology Awards 2019
Mogrify raises additional $16 million to advance its mission to transform the development of life-saving cell therapies
Mogrify appoints Dr. Jane Osbourn, OBE as Chair
Mogrify to host careers open day at Bio-Innovation Centre, Cambridge Science Park
Mogrify strengthens team and relocates to the Bio-Innovation Centre, TusPark Cambridge
Mogrify subsidiary Chondrogenix secures funding from SBRI Healthcare to advance regenerative cartilage therapy to the clinic
Mogrify wins Business Weekly award for ‘Disruptive Technology’
Mogrify awarded $555,000 USD (£420,000 GBP) Innovate UK funding to accelerate regenerative cell therapies
Mogrify raises $3.7 million USD seed funding to accelerate its mission to transform cell therapy via direct cellular conversion

TWITTER